(NYSE: EVMN) (the “Company” or “Evommune”), a clinical-stage biotechnology company developing therapies for chronic ...
The indictment alleges that on Sept. 18, 2026, Ellis caused serious physical injury to another person in a matter of domestic ...
CLARITY-101 Phase 1/1b clinical trial initiated and cleared by multiple global regulatory authorities, includingthe U.S. Food and Drug Administration (FDA) -- -- New preclinical data highlighting ...
Police say Prashant Pandya, 45, never held a Tennessee veterinary license but presented himself as a DVM at an East Nashville ...
Nxera to receive US$100 million upfront and be eligible for up to US$1.37 billion in development and commercial milestone ...
Under the terms of the agreement, Minghui will receive an upfront payment of USD 110 million and will be eligible to receive ...
THE BLUE TSUNAMI WAS CAUSED BY A LATINO EARTHQUAKE. Two years after helping Donald Trump return to the presidency, Latino ...
Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development, and commercialization of novel, ...
At EICMA 2026, Phelon & Moore presents the Capetown 5X and Capetown 5 Rally, two compact adventure bikes positioned below the ...
In-licensing of ex-China rights to two potentially best-in-class compounds (NXP100 and NXP200) from Haisco Pharmaceutical Group transformed Nuvectis into a late-stage clinical development company.The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results